The relationship between dietary flavonoid intake and hypertension: a cross-sectional study from NHANES
Frontiers in Cardiovascular Medicine · 30.05.2025 · 12
DOI: 10.3389/fcvm.2025.1518549 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 30.05.2025. Verfasst von Yueyue Niu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cadres Health Protection Department, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the association between dietary flavonoid intake and hypertension using nationally representative data, considering increasing global hypertension prevalence and inconsistent evidence on flavonoids’ protective effects.
Methods
This cross-sectional study analyzed 8,054 adults aged ≥20 years from NHANES 2007–2010 and 2017–2018. Flavonoid intake was assessed through two 24-hour dietary recalls and categorized into quartiles. Hypertension was defined by blood pressure ≥130/80 mmHg or self-reported diagnosis/medication use. Logistic regression models with progressive adjustment, restricted cubic spline regression for dose-response relationships, and subgroup analyses were conducted, accounting for complex sampling design.
Results
After full adjustment, participants in the highest quartile of total flavonoid intake showed 25% lower odds of hypertension compared to the lowest quartile (OR = 0 .75, 95% CI: 0.60–0.93, p = 0.01). Among flavonoid subclasses, anthocyanidins (OR = 0 .74, 95% CI: 0.58–0.93) and flavan-3-ols (OR = 0 .76, 95% CI: 0.62–0.93) demonstrated the strongest protective associations. Significant effect modifications were observed for age ( p for interaction = 0.01), hyperlipidemia ( p for interaction <0.0001), and cardiovascular disease status ( p for interaction =0.01), with stronger protective effects in younger adults and those without metabolic disorders.
Conclusion
Moderate dietary flavonoid intake, particularly anthocyanidins and flavan-3-ols, is inversely associated with hypertension risk. These associations vary significantly by age and metabolic status, suggesting potential for individualized dietary recommendations for hypertension prevention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cadres Health Protection Department, China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, China.
- Chinese and Western Medicine Collaborative Diagnosis and Treatment Medical Center, Xinjiang Uygur Autonomous Region People's Hospital, Urumqi, Xinjiang, China.
Zitieren
APA
Niu, Y., Chen, X., Xiao, L., Li, W., Feng, L., & Aierken, A. (2025). The relationship between dietary flavonoid intake and hypertension: a cross-sectional study from NHANES. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1518549
Vancouver
Niu Y, Chen X, Xiao L, Li W, Feng L, Aierken A. The relationship between dietary flavonoid intake and hypertension: a cross-sectional study from NHANES. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1518549
BibTeX
@article{Niu2025,
author = {Niu, Yueyue and Chen, Xingjuan and Xiao, Lu and Li, Weina and Feng, Ling and Aierken, Aikeremu},
title = {The relationship between dietary flavonoid intake and hypertension: a cross-sectional study from NHANES},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1518549}
}
EUVIMED